DE69315752D1 - Tieftemperatur-Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Sulfonaten - Google Patents

Tieftemperatur-Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Sulfonaten

Info

Publication number
DE69315752D1
DE69315752D1 DE69315752T DE69315752T DE69315752D1 DE 69315752 D1 DE69315752 D1 DE 69315752D1 DE 69315752 T DE69315752 T DE 69315752T DE 69315752 T DE69315752 T DE 69315752T DE 69315752 D1 DE69315752 D1 DE 69315752D1
Authority
DE
Germany
Prior art keywords
deoxy
difluoro
enriched
preparation
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69315752T
Other languages
English (en)
Other versions
DE69315752T2 (de
Inventor
Ta-Sen Chou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25415642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69315752(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69315752D1 publication Critical patent/DE69315752D1/de
Application granted granted Critical
Publication of DE69315752T2 publication Critical patent/DE69315752T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69315752T 1992-06-22 1993-06-21 Tieftemperatur-Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Sulfonaten Expired - Lifetime DE69315752T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/902,301 US5401861A (en) 1992-06-22 1992-06-22 Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates

Publications (2)

Publication Number Publication Date
DE69315752D1 true DE69315752D1 (de) 1998-01-29
DE69315752T2 DE69315752T2 (de) 1998-04-23

Family

ID=25415642

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69315752T Expired - Lifetime DE69315752T2 (de) 1992-06-22 1993-06-21 Tieftemperatur-Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Sulfonaten

Country Status (15)

Country Link
US (1) US5401861A (de)
EP (1) EP0576229B1 (de)
JP (1) JP3379994B2 (de)
KR (1) KR100312389B1 (de)
AT (1) ATE161264T1 (de)
BR (1) BR9302428A (de)
CA (1) CA2098886C (de)
DE (1) DE69315752T2 (de)
DK (1) DK0576229T3 (de)
ES (1) ES2112389T3 (de)
GR (1) GR3026210T3 (de)
HU (1) HU216840B (de)
IL (1) IL106076A (de)
MX (1) MX9303710A (de)
TW (1) TW233299B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (de) * 1983-08-18 1991-10-30 Beecham Group Plc Antivirale Guanin-Derivate
US5424416A (en) * 1993-08-25 1995-06-13 Eli Lilly And Company Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides
MY164523A (en) * 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
EP1294735A2 (de) 2000-05-26 2003-03-26 Novirio Pharmaceuticals Limited Verfahren und zusammensetzungen zur behandlung von flaviviren und pestiviren
US7608600B2 (en) * 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
NZ537662A (en) * 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
MXPA04012802A (es) * 2002-06-28 2005-04-19 Idenix Cayman Ltd Ester 2'-c-metil-3'-o-l-valina de ribofuranosil-citidina para el tratamiento de infecciones por flaviviridae.
US7824851B2 (en) * 2002-11-15 2010-11-02 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
WO2004052899A2 (en) * 2002-12-12 2004-06-24 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides
RU2007102281A (ru) * 2004-06-23 2008-07-27 Айденикс (Кайман) Лимитед (Ky) 5-аза-7-деазапуриновые производные для лечения заболеваний, связанных с flaviviridae
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 Ｄ-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
US7858761B2 (en) * 2004-07-29 2010-12-28 Hanmi Pharm. Co., Ltd 1-α-halo-2,2-difluoro-2-deoxy-D-ribofuranose derivatives and process for the preparation thereof
WO2006070985A1 (en) * 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. METHOD FOR THE PREPARATION OF 2#-DEOXY-2#,2#-DIFLUOROCYTIDINE
EP1831236A4 (de) * 2004-12-30 2013-11-20 Hanmi Science Co Ltd Verfahren zur herstellung von 2'-deoxy-2',2'-difluorocytidin
ATE458743T1 (de) * 2005-03-04 2010-03-15 Fresenius Kabi Oncology Ltd Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'- difluor-d-ribufuranosylnukleosiden
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
BRPI0610950A2 (pt) * 2005-06-03 2010-08-03 Scinopharm Taiwan Ltd processo para produção de um sulfonato de 2-deoxi-2, 2-difluoro-d-ribofuranosil enriquecido de alfa anÈmero, e uso do mesmo para produção de um beta nocleosìdeo
AU2011202539B2 (en) * 2005-06-03 2012-07-05 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
AT502221A1 (de) * 2005-07-20 2007-02-15 Pharmacon Forschung & Beratung Gmbh Homogemcitabine, verfahren zu ihrer herstellung sowie deren verwendung
US7781576B2 (en) * 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
KR101357409B1 (ko) 2006-11-03 2014-02-03 에스티팜 주식회사 2′-데옥시-2′,2′-디플루오로시티딘의 제조방법
WO2008117955A1 (en) * 2007-03-23 2008-10-02 Dongwoo Syntech Co., Ltd. Process for preparing of 2'-deoxy-2'2'-difluorocytidine
KR100858842B1 (ko) 2007-03-23 2008-09-22 동우신테크 주식회사 키랄아민을 이용한 광학활성 옥소라이보스유도체의제조방법
CN100475832C (zh) * 2007-05-31 2009-04-08 南京卡文迪许生物工程技术有限公司 一种新颖的高立体选择性合成吉西他滨工艺及中间体
CN109796506A (zh) * 2019-01-28 2019-05-24 江苏八巨药业有限公司 一种吉西他滨关键中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
ES2176279T3 (es) * 1987-08-28 2002-12-01 Lilly Co Eli Procedimiento estereoselectivo para preparar 2`-2`-difluorolactonen protegidos.
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides

Also Published As

Publication number Publication date
IL106076A0 (en) 1993-10-20
ATE161264T1 (de) 1998-01-15
HU216840B (hu) 1999-09-28
TW233299B (de) 1994-11-01
US5401861A (en) 1995-03-28
JP3379994B2 (ja) 2003-02-24
BR9302428A (pt) 1994-01-11
EP0576229A1 (de) 1993-12-29
CA2098886A1 (en) 1993-12-23
EP0576229B1 (de) 1997-12-17
CA2098886C (en) 2005-08-09
KR100312389B1 (ko) 2002-06-20
DK0576229T3 (da) 1998-01-19
HU9301827D0 (en) 1993-09-28
IL106076A (en) 2002-02-10
ES2112389T3 (es) 1998-04-01
GR3026210T3 (en) 1998-05-29
KR940005655A (ko) 1994-03-22
HUT64552A (en) 1994-01-28
JPH0656866A (ja) 1994-03-01
MX9303710A (es) 1994-01-31
DE69315752T2 (de) 1998-04-23

Similar Documents

Publication Publication Date Title
DE69315752D1 (de) Tieftemperatur-Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Sulfonaten
DE69312176D1 (de) Verfahren zur Herstellung von mit Alpha-Anomeren angereichterten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl Sulfonaten
JPS6470176A (en) Method of base-coating and clear-coating
EP0237251A3 (de) Membran
ES2103433T3 (es) Procedimiento para preparar derivados de 1-halo-2-desoxi-2,2-difluoro-d-ribofuranosilo enriquecidos en anomero alfa.
DE3584571D1 (de) Hydrokrackkatalysatoren und -verfahren mit nichtzeolitischen molekularsieben.
DE3784988D1 (de) Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.
ATE149505T1 (de) Verfahren zur trennung von 2-deoxy-2,2-difluor-d- ribofuranosyl-alkyl-sulfonat-anomeren
ES2001007B3 (es) Procedimiento para la obtencion de alquiltioalcanoatos.
DE68904797D1 (de) Verfahren zur herstellung von 4-demethoxydaunomycinon.
ES2052531T3 (es) Metodo para aumentar selectivamente la relacion de los componentes individuales del complejo antibiotico a 40926.
ES2094623T3 (es) Procedimiento estereoselectivo para la preparacion de 2-desoxi-2,2-difluoro-d-ribofuranosil-3,5-hidroxi protegido-1-alquil y aril-sulfonatos intermedios enriquecidos en el anomero beta.
DE69323352D1 (de) Verfahren zur Herstellung von mit Beta-Anomeren angereicherten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Aryl-Sulfonaten
ATE80383T1 (de) Verfahren zur herstellung sulfatierter alkanoloder alkylphenol-oxethylate mit erniedrigtem gehalt an 1,4-dioxan.
ATE60055T1 (de) Verfahren zur herstellung von n-methyl-lysergol.
IT1201252B (it) Procedimento per la decurazione di pelli con vello di pelo ed altro,con coloranti trasferiti da supporto
SE8902698D0 (sv) Baerregel foer takpannor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN